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Abstract: The compound dichlorido-copper(II)-4-(2-5-bromobenzylideneamino)ethyl) 
piperazin-1-ium phenolate (CuLBS) was synthesized, characterized and screened for acute 
toxicity and protective activity against ethanol-induced gastric mucosal injury in rats. 
Gross microscopic lesions, biochemical and immunological parameters and histochemcial 
staining of glycogen storage were taken into consideration. Oral administration of CuLBS 
(30 and 60 mg/Kg) for two weeks dose-dependently flattened gastric mucosa, significantly 
increased gastric mucus and total acidity, compared with control group (P < 0.01). Serum 
levels of liver enzymes aspartate (AST) and alanine transaminases (ALT), pro-inflammatory 
(IL-6 and TNF-α) and anti-inflammatory (IL-10) cytokines in the rats exposed to ethanol 
induced ulceration have been altered. Administration of CuLBS showed considerable  
(P < 0.05) protection against ulceration by modulating the acute alterations of cytokines 
AST, ALT and stomach glycogen. Interestingly, CuLBS did not interfere with the natural 
release of nitric oxide. CuLBS alone (60 mg/Kg) did not exhibit any ulcerogenic effect as 
assessed using Adami’s scoring scale. An acute toxicity study showed that rats treated with 
CuLBS (1,000 and 2,000 mg/Kg) manifested no abnormal signs. These findings therefore, 
suggested that the gastroprotective activity of CuLBS might contribute in modulating the 
inflammatory cytokine-mediated oxidative damage to gastric mucosa. 
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1. Introduction 
The inflammation caused by ethanol-induced gastric injuries has now become a standard measure 
for testing the therapeutic potencies of many synthetic compounds. Studies on compounds with  
anti-ulceragenic activities, both synthetic and those isolated from plant extracts, is now attracting the 
interest of many researchers [1] The use of ethanol as an ulcer model on experimental rats was 
observed to caused an intense infiltration of submucosa, affect the production of nitric oxide synthase, 
enhance the formation of reactive oxygen species (ROS), deplete mucus membrane, gastric pH and 
blood flow and subsequently damage of gastric mucosa ensued. The pathogenesis caused by this ulcer 
model also involved inhibition of the enzyme cyclooxygenase, which in turn suppressed the output of 
endogenous prostaglandins leading to changes in gastric motility [2]. Peptic ulcers have now become a 
global problem and one of the most common chronic illnesses among youths [3]. The therapeutic 
potentials of many compounds can be evaluated according to how they act to enhance gastric 
protection from the attack of ulcer models. Compounds containing a piperazine moiety have showed 
therapeutic potency in many biological studies [4,5] and the efficacy of such compounds was observed 
to increase after complexation [6]. Moreover, piperazine derivatives afford biologically active 
compounds against enzyme and receptor targets, for example a potent HIV protease inhibitor indinavir 
that has been approved for use in man or clozapine, an antipsychotic agent that blocks dopamine and 
potent MC4-receptor, to mention a few examples where a piperazine core has been used as a scaffold 
to produce biologically active compounds. This makes the piperazine core a privileged motif for drug 
design [7]. Meanwhile, Schiff bases are considered to be an important class of organic compounds in 
medicinal and pharmaceutical chemistry [8,9] and the exploration of novel Schiff base derivatives with 
chemotherapeutic potential is attracting the attention of many chemists [10]. Schiff bases containing 
piperazine heterocyclic ring (moieties) were reported to possess a broad spectrum of biological 
activities such as antiviral [11], anticancer [12], anticonvulsant, acetylcholinesterase inhibition [13] 
anti-PAF [14] anti-HIV [15], etc. Generally, Schiff bases show fascinating chelating behavior in 
coordinating with metal ions which makes them important radiopharmaceuticals for cancer treatment, 
in agrochemicals and as models for biological systems [16,17]. 
Copper is an essential element that serves as a cofactor for metalloenzymes that bind plasma to 
form cerloplasmin found in the liver [18]. Copper is involved in many biological systems [19-21] and 
this has attracted the attention of many researchers to determine its mechanisms of absorption [22,23] 
distribution [24] metabolism, and excretion [25]. The diseases cause by copper deficiency or excess 
were also investigated [26,27]. This study therefore, aimed to synthesize, characterize and evaluate the 
copper complex derived from the Schiff base bromosalicylaldimino-ethylpiperazine for acute toxicity and 
protective activity against ethanol-induced gastric injuries. 
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2. Results and Discussion 
The reaction of 5-bromosalicylaldehyde with 2-(piperazin-1-yl)ethanamine produces the Schiff base 
(E)-4-bromo-2-((2-(piperazin-1-yl)ethylimino)methyl)phenol, while treatment of this Schiff base with 
copper(II) chloride resulted in the formation of compound CuLBS. The IR spectra of the Schiff base 
showed absorption at 1,638 cm−1 which can be afforded to azomethine. This absorption shifted to  
1,633 cm−1 in the spectra of CuLBS due to complexation (Figure 1). This is confirmed at 640 nm, 
ascribed to metal-imine (M–N) bond formation. The UV-visible spectra also indicate absorption at  
636 nm that can be attributed to d-d electronic transition in the compound CuLBS. This absorption was 
absent in the spectra of the Schiff base. However, the 1H-NMR spectra of the compound CuLBS was 
not clear possibly due to paramagnetic nature of the copper ion. 
Figure 1. Molecular structures of CuLBS complex. 
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The oral administration of the compound CuLBS for 14 days resulted in no significant changes in 
the weight of the rats utilized in this study (Table 1). The results obtained from histological evaluations 
of liver and kidney showed no significant differences between the control and the rats pre-treated with 
CuLBS (Figures 2I–VI). In addition, the biochemical parameters for renal and liver functions of the 
normal rats and the rats pre-treated with CuLBS were in close agreement (Tables 2 and 3). The 
gastroprotective efficacy of the compound was further evaluated against ethanol-induced gastric 
ulcerations in rats. Pre-treatment with 30 mg/Kg and 60 mg/Kg were found to inhibit gastric mucosal 
injury caused by ethanol (Figures 3III and 3IV). This inhibitory effect was highest in the 60 mg/Kg 
group, which indicates that the compound protects the gastric mucosa dose-dependently. Similarly,  
30 mg/Kg of CuLBS significantly inhibited ethanol-induced gastric lesions compared to the control. 
Table 1. Effects of CuLBS on body and organ weights. 
Groups I II III IV V VI 
Body wt 190 ± 11.0 200 ±9.00 205 ± 10.0 215 ± 10.0 195 ± 10.0 193 ± 8.00 
Liver wt 2.89 ± 0.20 2.96 ± 0.18 3.21 ± 0.21 3.39 ± 0.19 2.92 ± 0.10 3.11 ± 0.20 
Kidney wt 1.34 ±0.03 1.29 ± 0.02 1.36 ± 0.05 1.39 ± 0.03 1.32 ± 0.02 1.35 ± 0.04 
The gastric mucus, which consists of a viscous, elastic, adherent and transparent gel formed by 
water and glycogens covering the entire gastrointestinal mucosa plays an important role in protecting 
it. The protective activity of the mucus barrier relies on that gel structure and the thickness of the layer 
covering the mucosal surface [28]. This study found that the compound CuLBS enhanced the 
production of gastric adherent mucus (Figures 4III and 4IV), increased mucus secretion and decrease 
gastric acidity at both doses. This enables the mucus layer to protect the newly formed cells against 
damage caused by ethanol (Figures 5III and 5IV). 
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Figure 2. Histological sections of liver and kidney in acute toxicity test. (2I and 2II) Rats 
treated with 5 mL/Kg vehicle (CMC); (2III and 2IV) Rats treated with 1 g/Kg (5 mL/Kg) 
CuLBS; (2V and 2VI) Rats treated with 2 g/Kg (5 mL/Kg) CuLBS. There is no significant 
differences in morphological structures of liver and kidney between treated and control 
groups (H & E stain 20×). 
 
Table 2. Renal function test of rats in acute toxicity study of CuLBS compound. 
Animals Na
+ 
(mmol/L)
K+ 
(mmol/L) 
Cl− 
(mmol/L)
CO2 
(mmol/L)
AG 
(mmol/L)
Urea 
(mmol/L) 
Crt 
(µmol/L)
Control 132 ± 3.1 6.31 ± 1.3 120 ± 1.4 26 ± 1.5 20.8 ± 1.5 6.2 ± 1.6 45.8 ± 2.4
LD (1 g/Kg) 131 ± 2.4 6.42 ± 1.2 119 ± 1.7 25 ± 1.5 21.8 ± 1.6 6.5 ± 1.9 43.9 ± 2.6
HD (2 g/Kg) 134 ± 2.2 6.63 ± 1.4 122 ± 1.3 28 ± 1.2 21.6 ± 1.4 6.4 ± 1.3 46.3 ± 2.2
Values expressed as mean ± S.E.M. There are no significant differences between groups. 
Significant value at p < 0.05. 
Table 3. Liver function test of rats in acute toxicity study of CuLBS compound. 
Values expressed as mean ± S.E.M. There are no significant differences between groups. 
Significant value at p < 0.05 T. Prot; total protein, TB: Total bilirubin; CB: Conjugated bilirubin; 
AP: Alkaline phosphatase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase;  
AG: anion gap; Crt: creatinine. 
Animals T. Prot. 
(g/L) 
Albumin 
(g/L) 
Globulin 
(g/L)
TB 
(µmol/L)
CB 
(µmol/L)
AP  
(IU/L) 
ALT 
(IU/L) 
AST 
(IU/L)
Control 78 ± 1.3 46.2 ± 1.8 39.6 ± 1.3 9.5 ± 1.8 1 128 ± 1.91 62 ± 1.3 249 ± 3.2
LD (1 g/kg) 77 ± 1.6 47.2 ± 1.3 37.8 ± 1.4 9.6 ± 1.6 1 127 ± 1.62 65 ± 1.4 248 ± 3.5
HD (2 g/Kg) 79 ± 1.8 48.5 ± 1.4 38.7 ± 1.6 9.8 ± 1.2 1 129 ± 1.67 64 ± 1.6 251 ± 3.1
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Figure 3. Gross appearance of the gastric injuries in rats. (3I) Rats pre-treated with  
5 mL/Kg distilled water (ulcer control). Severe injuries are seen in the gastric mucosa 
(arrow). Absolute ethanol produced extensive visible hemorrhagic necrosis of gastric 
mucosa; (3II) Rats pre-treated with omeprazole (20 mg/Kg). Injuries to the gastric mucosa 
are very milder (arrow) compared to the injuries seen in the ulcer control rats; (3III) Rat 
pre-treated with CuLBS (30 mg/Kg) and then followed with ethanol (CuLBS-Et,  
30 mg/Kg). Mild to moderate injuries are seen in the gastric mucosa (arrow). The 
compound reduces the formation of gastric lesions induced by absolute ethanol; (3IV) Rats 
pre-treated with CuLBS (60 mg/Kg) and then followed with ethanol (CuLBS-Et, 60 mg/Kg) 
Very mild injuries are seen in the gastric mucosa (arrow); (3V) Rats pre-treated with 
CuLBS alone (60 mg/Kg), no injuries to the gastric mucosa are seen (3VI). The normal 
rats, no injuries to the gastric mucosa are seen. 
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Figure 4. Histological view of the ethanol-induced gastric mucosal damage in rats.  
(4I) Rats pre-treated with 5 mL/Kg of distilled water (ulcer control). There is severe 
disruption to the surface epithelium and necrotic lesions penetrate deeply into mucosa 
(white arrow) and extensive edema of submucosa layer and leucocyte infiltration are 
present (black arrow); (4II) Rats pre-treated with omeprazole (20 mg/Kg). Moderate 
disruption of the surface epithelium mucosa is present (white arrow) but deep mucosal 
damage is absent. Submucosal edema and leucocytes infiltration (black arrow); (4III) Rat 
pre-treated with CuLBS (30 mg/Kg) and then followed with ethanol (CuLBS-Et, 30 mg/Kg). 
Mild disruption of surface epithelium is present but deep mucosal damage is absent. 
Submucosal edema and leucocytes infiltration (black arrow); (4IV) Rat pre-treated with 
CuLBS (60 mg/Kg) and then followed with ethanol (CuLBS-Et, 60 mg/Kg) Very mild 
disruption of surface epithelium is present but deep mucosal damage is absent. Submucosal 
edema and leucocytes infiltration (black arrow); (4V) Rats pre-treated with CuLBS-alone 
(60 mg/Kg).There are no disruption to the surface epithelium with no edema and no 
leucocytes infiltration of the submucosal layer; (4VI) The normal rats rats pre-treated with 
CMC alone. There is no disruption to the surface epithelium with no edema and no 
leucocytes infiltration of the submucosal layer (H & E stain; 10×). 
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Figure 5. Effect of CuLBS on gastric tissue glycogen-PAS staining. Stomach subjected to 
ethanol-induced ulcer after treatment with CMC (5I); CuLBS (30 mg/Kg) (5II), CuLBS 
(60 mg/Kg) (5III) and the normal rat stomach (5IV). 
 
The ethanol model is widely used to assess the protective and healing activity of many drugs in 
ulcer studies [29] due to its ability to reduce endogenous NO level and blood flow in gastric mucosa, 
which leads to a serious hemorrhagic necrosis and consequently depletes gastric mucus constituents [30] 
resulting in an increased flow of Na+ and K+, elevated pepsin secretion, loss of H+ ions and histamine  
into the lumen [31]. In our effort to investigate the mechanism involved in the action of this compound, 
we evaluated the level of liver enzymes AST, ALT, the energy storage creatinine, the high density  
lipo-protein and the leukocyte count between the ethanol group and the groups pre-treated with 
CuLBS. The results showed that rats induced with ethanol ulceration had increased level of liver 
enzymes AST and ALT compared to normal and the rats that received CuLBS, this rise was more 
noticeable with AST which can be ascribed to alcoholic hepatitis due to ethanol. Pre-treatment with 
CuLBS dose-dependently reduces this liver toxicity caused by ethanol. The creatinine level, high 
density lipoprotein, leukocyte count and c-reactive enzymes were also altered in the acute ulcerated 
rats compared to the normal and rats pre-treated with CuLBS (Table 4). However, the rats pretreated 
with CuLBS showed a decreased in such parameters. This can presumably be due to high activity of 
the compound to protect the gastric from ethanol induced injuries. Moreover, pre-treatment with 
CuLBS to ulcer induced rats has led to the flattening of mucosal folds, increased pH and gastric mucus 
content (Table 5) ensuring the protective activity of this novel copper complex. 
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Table 4. Biochemical parameters in gastroprotectivity study of CuLBS. 
Animals Treatments ALT (IU/L) AST (IU/L) C-reactive HDL Creatinine WBC 
I CMC (ulcer control) 94.23 ± 8.2 296.2 ± 9.2 0.18 ± 0.04 0.09 ± 0.4 21.2 ± 1.9 4.16 ± 2.1 
II Omeprazole (20 mg/Kg) 65.22 ± 4.2 189.4 ± 7.6 0.63 ± 0.10 1.22 ± 0.5 47.9 ± 9.2 9.23 ± 3.2 
III CuLBS-Et-(30 mg/Kg) 67.31 ± 3.4 193.3 ± 8.4 0.65 ± 0.09 1.24 ± 0.3 48.6 ± 1.5 9.31 ± 2.7 
IV CuLBS-Et-(60 mg/Kg) 68.42 ± 5.2 195.7 ± 7.2 0.67 ± 0.04 1.26 ± 0.3 51.3 ± 2.3 10.21 ±3.2 
V CuLBS-alone-0 mg/Kg 59.61 ± 4.6 196.5 ± 6.4 0.55 ± 0.06 1.20 ± 0.4 45.2 ± 9.6 9.11 ± 1.3 
VI Normal 64.28 ± 4.7 194.9 ± 7.1 0.69 ± 0.07 1.25 ± 0.6 52.6 ± 7.3 10.61 ± 2.3 
Table 5. Observed ulcer area and %Inhibition. 
Animal Pretreatment  (5 mL/Kg) Gastric pH 
Mucus wt 
(g) 
Ulcer area 
(mm) %Inhibition
I CMC (ulcer control) 1.43 ± 0.7 0.95 ± 1.3 962.19 ± 12.62 - 
II Omeprazole (20 mg/Kg) 4.92 ± 0.6 3.65 ± 1.2 189.24 ± 9.6 80.30 
III CuLBS-Et- (30 mg/Kg) 5.36 ± 1.2 4.47 ± 2.3 125.62 ± 5.3 86.94 
IV CuLBS-Et- (60 mg/Kg) 6.98 ± 1.4 5.31 ± 2.8 104.45 ± 4.6 89.14 
V CuLBS-alone- 60 mg/Kg 5.14 ± 0.9 3.82 ± 1.6 0 100 
VI Normal 3.28 ± 1.9 3.28 ± 1.8 0 100 
Ulcer area expressed as (mean + S.E.M). 
Interleukins play an important role in the regulation of the mucosal defense barrier. Levels of  
pro-inflammatory cytokines such as IL-6 and TNF-α in the gastric mucosa were significantly increased 
while the anti-inflammatory IL-10 was significantly decreased in gastric injury models (Table 6). 
However, in ethanol induced rats, the anti-inflammatory marker IL-10 decreased, whereby the CuLBS 
treated groups inhibited the depletion of this cytokine, which proves the role played by CuLBS in 
gastric protection. To describe the effect of CuLBS on the gastric inflammation, the level of 
inflammatory mediator (NO) and lipid peroxidation were evaluated. Ethanol induction notably 
decreased the level of NO, but pre-treatment with CuLBS enhances the production of NO and inhibit 
lipid peroxidation. It was reported that nitric oxide (NO) synthesis protect the gastric mucosa against 
damage induced by various ulcer models and that the serum and local NO levels are reduced in gastric 
injury models induced by ethanol and indomethacin [32]. This indicates that the decrease in local NO 
content might be a key factor in facilitating gastric mucosal injury [33]. 
Table 6. Effects of CuLBS on MDA, NO, TNF-α, IL-6 and IL-10 in ulcerated in rats. 
Animals MDA  (µmol/g Tissue) 
NO  
(µmol) 
TNF-α 
(pg/mg) 
IL-6  
(pg/mg) 
IL-10 
(pg/mg) 
I 25.32 ± 1.27 a 3.32 ± 0.03 361 ± 3.8 67 ± 2.1 72 ± 6.2 
II 13.65 ± 1.49 b 7.85 ± 0.04 94.0 ± 2.8 10.4 ± 1.5 264 ± 4.5 
III 12.21 ± 1.32 c 9.42 ± 0.09 45.0 ± 4.5 6.20 ± 1.8 289 ± 3.3 
IV 10.25 ± 0.85 c 9.92 ± 0.85 21.4 ± 0.4 4.50 ± 1.6 342 ± 2.1 
V 14.16 ± 1.23 c 6.83 ± 1.20 0 0 258 ± 5.2 
VI 12.51 ± 1.12 c 8.93 ± 1.13 0 0 239 ± 6.5 
Group I: CMC + EtOH; GroupII: animals that received omeprazole + ethanol; Group III: animals that 
received CuLBS (30 mg/Kg + EtOH); Group IV: animals that received CuLBS (60 mg/Kg + EtOH), 
Group V: animals that received CuLBS (60 mg/Kg) alone; Group VI: Normal animals. 
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3. Experimental 
3.1. General 
Elemental analysis was conducted on Costech Elemental Combustion System CNHS-O elemental 
analyzer, NMR was performed on ECA-400 higher performance FTNMR Spectrophotometer, IR 
spectra were recorded on Perkin-Elmer FTIR Spectrophotometer, UV-visible spectroscopy was carried 
out on Perkin-Elmer-1650-UV-visible spectrophotometer. 5-bromosalicylaldehyde, 2-(piperazin-1-
yl)ethanamine, copper(II) chloride salt, solvents and all other chemicals were purchased from  
Merk-Aldrich, Kuala Lumpur, Malaysia. 
3.2. Synthesis and Isolation of CuLBS 
To a stirred solution of 2-(piperazin-1-yl)ethanamine (1.29 g, 10 mmol) in ethanol (25 mL) an 
equimolar stirred solution of 5-bromosalicylaldehyde (2.0 g, 10 mmol) in ethanol (25 mL) was added 
dropwise at room temperature and then refluxed for 3 h at 75–85 °C. An orange solution was obtained, 
which after removing the solvent gave a red oil. After stabding for 3 days the red oil forms a hygroscopic 
solid which is dissolved in methanol (50 mL) by heating to a temperature of 60–65 °C followed by 
addition of a few drops of sodium hydroxide (1 M). A few drops of diethyl ether were added to the 
solution while it is hot, and a reddish-yellow solid appeared, which is filtered off immediately and 
dried under vacuum. The solid was recrystallized from methanol and collected after concentrating and 
cooling, washed with ethanol-water mixture (20:80) and dried under vacuum. The compound was 
characterized by IR, NMR and UV-visible spectroscopy. The pH and pKa of the compound was also 
determined. Yield: (0.24 g, 76.9%). IR (KBr disc cm−1): υ(NH–/OH), 3421sb; υ(C–H), 2736s; υ(C=N), 
1638s, υ(C–C), 1458s; υ(C–N), 1176s; υ(Br–Ar), 688s. 1H-NMR (DMSO-d6), δ, ppm: 2.0 (s, 1H, NH), 
2.48 (t, 2H, 2CH2), 6.78–7.02 (d, 1H, ArH), 8.54 (s, 1H, imine), 11.26 (s, 1H, phenolic) 13C-NMR 
(DMSO-d6), δ, ppm: 18.96 (CH3), 39.84–40.47 (DMSO-d6 + CH2), 54.51-59.06 (CH2), ArC: [108.95 
(CH), 120.00 (CH), 133.90 (CH), 135.36 (CH), 161.77 (CH), 165.65 (CH)]; m/z: 310.09, 311.02, 
314.07. pH, 9.13; pKa, 2.73. UV-Vis (DMSO), λmax (ε, Mol−1cm−1): 279 nm (3091.79, π-π*); 303 nm 
(3152.21, CT). 
To a measured quantity of the synthesized Schiff base (0.312 g, 1 mmol) dissolved in methanol  
(25 mL) was added a weighed quantity of copper(II) chloride (0.17 g, 1 mmol) also in methanol  
(25 mL) at room temperature with stirring, followed with a few drops of potassium hydroxide (1 M). 
The solution immediately forms a green precipitate that was filtered off, washed with ethanol-water 
mixture (80:20) and dried in a vacuum desiccator, yield (0.34 g (76.4%)). Anal. Calc. for 
C13H17BrCl2CuN3O: C, 35.04; H, 3.84; N, 9.43. Found; C, 30.76; H, 3.24; N, 8.46. IR (KBr disc 
cm−1): υ(NH–/OH), 3434s; υ(C–H), 2737s; υ(C=N), 1633s, υ(C–C), 1457s; υ(C–N), 1177s; υ(phenyl 
ring), 906; υ(M–O), 690s; υ(M–N), 640s. UV-Vis (DMSO), λmax (ε, mol−1cm−1): 274 nm (2527.6,  
π-π*); 377 nm (1,535.2, LMCT); 636 nm (142.62, d-d). The proposed structure is shown in Figure 1. 
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3.3. Animals 
Males Sprague Dawley rats weighing about 180 ± 50 g were obtained from the Animal House, 
Faculty of Medicine, University of Malaya (Kuala Lumpur, Malaysia). Rats were distributed into six 
groups of six rats each. The animals were fed with a standard pellet diet and tap water under controlled 
temperature conditions (22 ± 4 °C). Animals received human care according to approved institutional 
guidelines and experiments formulated by the National Academy of Sciences and published by the 
National Institute of Health, Malaysia. 
3.4. Estimation of Oral Acute Toxicity 
The acute toxicity of CuLBS was estimated according to the reported guidelines for testing of 
chemicals acute oral toxicity [34] using 2,000 mg/kg (high dose) and 1,000 mg/kg (low dose) body 
weight (b.w). Adult male and female Sprague Dawley rats (6–8 weeks old; 150–180 g) were obtained 
from the Experimental Animal House [Ethics No. PM 07/05/2008 MAA (a)(R)], Faculty of Medicine, 
University of Malaya. The animals were given standard food and clean water prior to dosing and then 
fasted 18 h before the administration of compound CuLBS. The overnight fasted animals were treated 
with CuLBS at doses of 1,000 and 2,000 mg/kg b.w., and the food was withheld for further 3–4 h after 
dosing. The animals were kept under observation for 14 days (Table 1) to examine any clinical, 
toxicological symptoms or mortality. The animals were sacrificed on the 15th day and all the 
biochemical parameters (Tables 2 and 3) and histological data (Figure 2) were analyzed. 
3.5. Ulcerogenic Study 
Group I and VI rats were given food and water for 14 days [35], Group II rats were treated with 
omeprazole dissolved in carboxymethylcellulose (CMC) and Group III and Group IV rats were orally 
administered CuLBS dissolved in carboxymethylcellulose (CMC) at 30 and 60 mg/Kg b.w., 
respectively, for 14 days. Rats in Group V received CuLBS alone for 14 days. The animals were fasted 
for 24 h on day 14. On day 15, group II, received omeprazole, Group III, IV and V were given CuLBS 
while Group I and VI received vehicle. One hour after this treatment, animals in Group I, II, III, IV and V 
received orally 95% ethanol at the dose of 5 mL/Kg. The animals were sacrificed 30 min latter by cervical 
decapitation under anesthetized xylazin and ketamine. Serum was obtained for biochemical analyses. 
3.6. Serum Biochemical Assays 
Blood samples were analyzed at University Malaya Medical Centre to evaluate changes in biomarkers. 
3.7. Measurement of Gastric Juice Acidity 
The stomachs of animals sacrificed were excised. The gastric contents was collected, centrifuged at 
4,000 rpm and the supernatant used for the determination of hydrogen ion concentration by titration 
with 0.1 N NaOH solution using digital pH meter. The acid content was expressed as mEq/L [36]. 
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3.8. Histopathological Studies 
The histological alterations observed in the gastric of ulcerated rats were assessed by fixing the 
gastric walls from each rat in 10% buffered formalin and processed in a Paraffin Tissue Processing 
Machine. Sections of the gastric were made at a thickness of 5 µM and stained with hematoxylin and 
eosin for histological evaluation. 
3.9. Gastroprotective Assessments 
Elongated bands of hemorrhagic lesions parallel to the long axis of the stomach were observed in 
the gastric of animals that received ethanol. The length (mm) and width (mm) of the ulcer on the 
gastric mucosa were measured using planimeter [(10 × 10 mm2 = ulcer area) under dissecting 
microscope (1.8×)]. The area of each ulcer lesion was measured by counting the number of small 
squares, 2 mm × 2 mm, covering the length and width of each ulcer band. The sum of the areas of all 
lesions for each stomach was applied in the calculation of the ulcer area (UA) wherein the sum of 
small squares × 4 × 1.8 = UA mm2. The inhibition percentage (I%) was calculated as described in [37] 
with slight modifications by the following formula: 
Inhibition percentage (I%) = [(UAcontrol − UAtreated) / UAcontrol] × 100%. 
3.10. Gastric Mucus Evaluations 
The gastric content was collected and centrifuged at 4,000 rpm for 10 min. The supernatant was 
removed and the mucus weighed using a precision electronic balance. 
3.11. PAS Staining 
To examine the extent of protection provided by CuLBS against ethanol-induced gastric lesions, 
gastric tissues were stained histochemically to evaluate the mucus content. Formalin fixed paraffin and 
embedded gastric tissues were sectioned, dewaxed and stained using a commercial PAS staining 
system kit (Sigma Aldrich, Malaysia) according to the manufacturer’s instructions [38]. 
3.12. Estimation of the Role of Total Nitric Oxide 
The concentration of nitric oxide in the gastric homogenate was evaluated as total nitrate/nitrite 
levels using the Griess reagent [39]. The stomach homogenates in 50 mM potassium phosphate buffer 
(pH 7.8) were centrifuged at 4,000 rpm for 30 min at 4 °C. Fifty μL of the Griess reagent (0.1%  
N-(1-naphthyl) ethylenediamidedihydrochloride, 1% sulfanilamide in 5% phosphoric acid) was added 
to supernatant (50 μL) and mixed, then after 10 min the absorbance was measured at 540 nm. The 
standard curves were obtained by using sodium nitrite. Results were expressed as micromoles 
nitrate/nitrite per gram of protein. 
3.13. Estimation of Membrane Lipids Peroxidation 
To evaluate the level of lipid peroxidation in the mucus membrane, the level of malondialdehyde 
was estimated using the thiobarbituric acid-reactive substances (as indicators of lipid peroxidation) 
Molecules 2011, 16 8665 
 
assay according to the reported procedure [40] with some modifications. The stomach homogenates 
were mixed with a solution (0.125 mL) containing 26 mM thiobarbituric acid, 0.26 M HCl, 15% 
trichloric acid and 0.02% butylatedhydroxytoluene. The mixtures were heated at 96 °C for 15 min and 
centrifuge at 4,000 rpm for 10 min. The supernatant was transferred to 96-well plate and the absorption 
was measured at 532 nm using tetramethoxypropane as standard. 
3.14. Estimation of IL-6, IL-10 and TNF-α 
To evaluate the extent at which the compound CuLBS reduce the inflammatory effects of ethanol- 
induced lesions in the ulcerated rats, the level of cytokines (IL-6, IL-10 and TNF-α) in the serum were 
evaluated using ELISA kits; ELR-IL6, IL-10 and TNF-alpha-001 for rats according to the 
manufacturer’s (Ray Biotech, Norcross GA, USA) instructions. Primary antibodies were first coated 
on the well plate and after washing, each well was blocked to remove the non-specific binding. One 
hundred microliters of sample or cytokine standards were added to each well and then followed with 
biotin conjugated secondary antibodies. To obtain a color reaction, streptavidin-HRP and substrate 
solution were added. The absorbance was measured at 450 nm with anan ELISA reader (TECAN, 
Mannedorf, Switzerland). Standard curves were plotted on each assay plate using recombinant IL-6, 
IL-10 and TNF-α in serial dilution. 
3.15. Estimation of Gastric Tolerance 
The ethanol induced gastric injuries were examined under an illuminated magnifier (3×) and scored 
according to a modified scoring system of Adami et al. [41] (0: no lesions; 0.5: slight hyperaemia or 
≤5 petechiae; 1: ≤5 erosions ≤5 mm in length; 1.5: ≤5 erosions ≤5 mm in length and many petechiae; 
2: 6–10 erosions ≤5 mm in length; 2.5: 1–5 erosions >5 mm in length; 3: 5–10 erosions >5 mm in 
length; 3.5: >10 erosions >5 mm in length; 4: 1–3 erosions ≤5 mm in length and 0.5–1 mm in width; 
4.5: 4–5 erosions ≤5 mm in length and 0.5–1 mm in width; 5: 1–3 erosions >5 mm in length and  
0.5–1 mm in width; 6: 4 or 5 grade 5 lesions; 7: ≥6 grade 5 lesions; 8: complete lesion of the mucosa 
with haemorrhage). 
3.16. Statistical Analysis 
All values were reported as mean ± S.E.M. The statistical significance of differences between 
groups was assessed using one-way ANOVA. A value of p < 0.05 was considered significant. 
4. Conclusions 
In conclusion, the compound CuLBS was observed to show protective activity by preserving the 
level of NO synthase, increasing the level of anti-inflammatory cytokine IL-10 and high density 
lipoprotein, inhibiting lipid peroxidation and decreasing the levels of pro-inflammatory cytokines IL-6 
and TNF-α. Such outcomes can be used as a guide for further research to determine the exact 
mechanistic action of this novel compound. 
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